Lantern Pharma's total assets for Q1 2026 were $7.22M, a decrease of -99.93% from the previous quarter. LTRN total liabilities were $3.78M for the fiscal quarter, a -99.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.